A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation

Skin Research and Technology

Volumn 7, Issue 4, 2001, Pages 227-237

  Perkins, M A ^a   Osterhues, M A ^a   Farage, M A ^a   Robinson, M K ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Cytokines; Dermatitis; Human skin; Immunoassay; Noninvasive method; Sebutape

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; DODECYL SULFATE SODIUM; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; PROTEIN; SODIUM CHLORIDE;

ADSORPTION; ADULT; ARM; ARTICLE; BACK; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DERMATITIS; DIAPER DERMATITIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FACE; FEMALE; HUMAN; HUMAN EXPERIMENT; LOWER LEG; MALE; MEDICAL ASSESSMENT; RASH; SCORING SYSTEM; SKIN DEFECT; SKIN INFLAMMATION; SKIN IRRITATION; SUN EXPOSURE; TEST STRIP; ULTRASOUND;

ADHESIVES; ADSORPTION; AGED; BIOLOGICAL MARKERS; CYTOKINES; DERMATITIS; ENVIRONMENTAL EXPOSURE; FOREARM; HUMANS; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-8; SIALOGLYCOPROTEINS; SKIN; SKIN DISEASES; SODIUM DODECYL SULFATE; SUNLIGHT; SURFACE-ACTIVE AGENTS; TIME FACTORS;

EID: 0035159620     PISSN: 0909752X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0846.2001.70405.x     Document Type: Article

References (33)

1. The skin as an immunological organ as well as a target for immune responses
2. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice
3. Perturbation of epidermal barrier function correlates with irritation of cytokine cascade in human skin
4. The use of in vitro skin recombinants to evaluate cutaneous toxicity
5. Responses of the EpiDerm skin model to topically applied skin irritants and allergens
6. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential
7. Treatment of adult atopic dermatitis with low dose (3mg/kg per day) cyclosporine
8. Immunosuppressive agents in skin disorders: A comparative review
9. Ketotifen: A review of its therapeutic efficacy in dermatological disorders
10. Changes in T-cell phenotype and adhesion molecules expression in psoriatic lesions after low dose cyclosporin therapy
11. A risk assessment process for allergic contact sensitization
12. Evaluation of the primary skin irritation and allergic contact sensitization potential of transdermal tripolidine
13. Risk assessment
14. A skin sensitization risk assessment approach for evaluation of new ingredients and products
15. Different skin irritation abilities of different qualities of sodium lauryl sulphate
16. Skin reactions to irritants assessed by polysulfide rubber replica
17. Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls
18. Efficacy of topical corticosteroids on irritant skin reactions
19. Assessment of mild irritants in humans
20. The invisible dermatoses
21. Measuring the chemosensory irritability of human skin
22. Cytokine mRNA expression in human epidermis after patch treatment with rhus and sodium lauryl sulfate
23. Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet-B irradiated human skin
24. An increased ratio of interleukin-receptor antagonist to interleukin-1α in inflammatory skin diseases
25. Determination of density of follicles on various regions of the face by cyanoacrylate biopsy: Correlation with sebum output
26. Development of a noninvasive method for assessing human skin irritation
27. Further development of a noninvasive method for assessing human skin irritation
28. Noninvasive method for assessing inflammatory changes in chemically treated skin
29. Reapplication of a novel noninvasive method for assessing the relationship of gingival inflammation and bleeding to gingival epithelium cytokine concentrations
30. Interleukin-1α is present in normal human epidermis
31. Application of a 4 hour human patch test method for comparative and investigative assessment of skin irritation
32. Evaluation of a human patch test for the identification and classification of skin irritation potential